Mayzent Logo

MAYZENT DISCUSSION GUIDE

Your experience with relapsing multiple sclerosis (RMS) is unique, so sharing details with your doctor can help ensure you receive the right treatment for you. Keep this discussion guide handy, and use it to help guide a conversation about how your symptoms may be changing, and if MAYZENT® may be right for you.

Your Responses image

I was first diagnosed with multiple sclerosis (MS) ago.

I still experiencing relapses.

I feel like I bouncing back in between relapses.

I had a recent MRI.

Overall, I like something is different or that my symptoms are changing.

I'm experiencing or feeling like the following have gotten worse compared to 6 to 12 months ago:

      These activities are more challenging now compared to 6 to 12 months ago:

      • Doing household chores
      • Being independent and doing things on your own
      • Participating in social activities
      • Spending time with, or taking care of, loved ones
      • Having the energy to leave your house
      Questions About Mayzent
      • Can MAYZENT slow down disability progression?
      • What should I know about starting MAYZENT?
      • Is it the right time to start MAYZENT?
      Questions About RMS
      • Do these changes I'm feeling mean my RMS is progressing?
      • I haven't had a relapse recently. Does that mean my RMS is not progressing?

      Tell your doctor about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements. Also tell your doctor about any other MS medications you've taken in the past.

      What is MAYZENT® (siponimod) tablets?

      MAYZENT is a prescription medicine that is used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

      It is not known if MAYZENT is safe and effective in children.

      IMPORTANT SAFETY INFORMATION

      Do not take MAYZENT if you:

      • have a CYP2C9*3/*3 genotype. Before starting treatment with MAYZENT, your CYP2C9 genotype should be determined by your health care provider. Ask your health care provider if you are not sure.
      • have had a heart attack, chest pain called unstable angina, stroke or mini-stroke (transient ischemic attack or TIA), or certain types of heart failure in the last 6 months
      • have certain types of heart block or irregular or abnormal heartbeat (arrhythmia), unless you have a pacemaker

      Please see additional Important Safety Information on pages 2-4 and full Prescribing Information, including Medication Guide, at mayzent.com.

      1

      Mayzent Logo

      NOTES

      IMPORTANT SAFETY INFORMATION (cont)

      MAYZENT® may cause serious side effects, including:

      1. Slow heart rate (bradycardia or bradyarrhythmia) when you start taking MAYZENT. MAYZENT can cause your heart rate to slow down, especially after you take your first dose. You should have a test to check the electrical activity of your heart called an electrocardiogram (ECG) before you take your first dose of MAYZENT.

        During the initial updosing period (4 days for the 1-mg daily dose or 5 days for the 2-mg daily dose), if you miss 1 or more doses of MAYZENT, you need to restart the updosing. Call your health care provider if you miss a dose of MAYZENT.

      2. Infections. MAYZENT can increase your risk of serious infections that can be life-threatening and cause death. MAYZENT lowers the number of white blood cells (lymphocytes) in your blood. This will usually go back to normal within 3 to 4 weeks of stopping treatment. Your health care provider should review a recent blood test of your white blood cells before you start taking MAYZENT. Call your health care provider right away if you have any of these symptoms of an infection during treatment with MAYZENT and for 3 to 4 weeks after your last dose of MAYZENT:

        • fever
        • tiredness
        • body aches
        • chills
        • nausea
        • vomiting
        • headache with fever, neck stiffness, sensitivity to light, nausea, confusion (these may be symptoms of meningitis, an infection of the lining around your brain and spine)
      1. Progressive multifocal leukoencephalopathy (PML). MAYZENT can increase your risk for PML, which is a rare brain infection that usually leads to death or severe disability. If PML happens, it usually happens in people with weakened immune systems but has happened in people who do not have weakened immune systems. Symptoms of PML get worse over days to weeks. Call your doctor right away if you have any new or worsening neurologic symptoms that have lasted several days, including:

        • weakness on 1 side of your body
        • loss of coordination in your arms and legs
        • decreased strength
        • problems with balance
        • changes in your vision
        • changes in your thinking or memory
        • confusion
        • changes in your personality
      2. A problem with your vision called macular edema. Macular edema can cause some of the same vision symptoms as a multiple sclerosis (MS) attack (optic neuritis). You may not notice any symptoms with macular edema. If macular edema happens, it usually starts in the first 1 to 4 months after you start taking MAYZENT. Your health care provider should test your vision before you start taking MAYZENT and any time you notice vision changes during treatment with MAYZENT. Your risk of macular edema is higher if you have diabetes or have had an inflammation of your eye called uveitis.

      Call your health care provider right away if you have any of the following: blurriness or shadows in the center of your vision, a blind spot in the center of your vision, sensitivity to light, or unusually colored (tinted) vision.

      Please see additional Important Safety Information on pages 1,3 and 4 and full Prescribing
      Information, including Medication Guide, at mayzent.com.

      2

      Mayzent Logo

      IMPORTANT SAFETY INFORMATION (cont)

      Before taking MAYZENT, tell your health care provider about all of your medical conditions, including if you:

      • have an irregular or abnormal heartbeat
      • have a history of stroke or other diseases related to blood vessels in the brain
      • have breathing problems, including during your sleep
      • have a fever or infection, or you are unable to fight infections due to a disease or are taking medicines that lower your immune system. Tell your health care provider if you have had chickenpox or have received the vaccine for chickenpox. Your health care provider may do a blood test for chickenpox virus. You may need to get the full course of vaccine for chickenpox and then wait 1 month before you start taking MAYZENT.
      • have slow heart rate
      • have liver problems
      • have diabetes
      • have eye problems, especially an inflammation of the eye called uveitis
      • had or now have a type of skin cancer called basal cell carcinoma (BCC), melanoma, or squamous cell carcinoma (SCC)
      • have high blood pressure
      • are pregnant or plan to become pregnant. MAYZENT® may harm your unborn baby. Talk to your health care provider right away if you become pregnant while taking MAYZENT or if you become pregnant within 10 days after you stop taking MAYZENT.
        • If you are a woman who can become pregnant, you should use effective birth control during your treatment with MAYZENT and for at least 10 days after you stop taking MAYZENT.
        • Pregnancy Registry: There is a registry for women who become pregnant during treatment with MAYZENT. If you become pregnant while taking MAYZENT, talk to your health care provider. For more information or to register, contact MotherToBaby by calling 1-877-311-8972, by sending an email to MotherToBaby@health.ucsd.edu, or go to www.mothertobaby.org/join-study.
      • are breastfeeding or plan to breastfeed. It is not known if MAYZENT passes into your breast milk. Talk to your health care provider about the best way to feed your baby if you take MAYZENT.

      Tell your health care provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements. Especially tell your health care provider if you take medicines to control your heart rhythm (anti-arrhythmics), or blood pressure (antihypertensives), or heart beat (such as calcium channel blockers or beta-blockers); take medicines that affect your immune system, such as beta-interferon or glatiramer acetate, or any of these medicines that you took in the past.

      Tell your health care provider if you have recently received a live vaccine. You should avoid receiving live vaccines during treatment with MAYZENT. MAYZENT should be stopped 1 week before and for 4 weeks after receiving a live vaccine. If you receive a live vaccine, you may get the infection the vaccine was meant to prevent. Vaccines may not work as well when given during treatment with MAYZENT.

      MAYZENT may cause possible side effects, including:

      • increased blood pressure. Your health care provider should check your blood pressure during treatment with MAYZENT.
      • liver problems. MAYZENT may cause liver problems. Your health care provider should do blood tests to check your liver before you start taking MAYZENT. Call your health care provider right away if you have any of the following symptoms of liver problems:
      • nausea
      • vomiting
      • stomach pain
      • tiredness
      • loss of appetite
      • your skin or the whites of your eyes turn yellow
      • dark urine
      • breathing problems. Some people who take MAYZENT have shortness of breath. Call your health care provider right away if you have new or worsening breathing problems.
      • swelling and narrowing of the blood vessels in your brain. A condition called PRES (Posterior Reversible Encephalopathy Syndrome) has happened with drugs in the same class. Symptoms of PRES usually get better when you stop taking MAYZENT. However, if left untreated, it may lead to a stroke. Call your health care provider right away if you have any of the following symptoms: sudden severe headache, sudden confusion, sudden loss of vision or other changes in vision, or seizure.

      Please see additional Important Safety Information on pages 1,2 and 4 and full Prescribing
      Information, including Medication Guide, at mayzent.com.

      3

      Mayzent Logo

      IMPORTANT SAFETY INFORMATION (cont)

      • severe worsening of multiple sclerosis after stopping MAYZENT. When MAYZENT is stopped, symptoms of MS may return and become worse compared to before or during treatment. Always talk to your doctor before you stop taking MAYZENT for any reason. Tell your health care provider if you have worsening symptoms of MS after stopping MAYZENT.
      • a type of skin cancer called basal cell carcinoma (BCC), melanoma, and squamous cell carcinoma (SCC). Tell your doctor if you have any changes in the appearance of your skin, including changes in a mole, a new darkened area on your skin, a sore that does not heal, or growths on your skin, such as a bump that may be shiny, pearly white, skin-colored, or pink. Your doctor should check your skin for any changes at the start of and during treatment with MAYZENT. Limit the amount of time you spend in sunlight and ultraviolet (UV) light. Wear protective clothing and use a sunscreen with a high sun protection factor.

      The most common side effects of MAYZENT include: headache, high blood pressure (hypertension), and abnormal liver tests.

      These are not all of the possible side effects of MAYZENT. Call your doctor for medical advice about side effects.

      You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

      Please see additional Important Safety Information on pages 1-3 and full Prescribing
      Information, including Medication Guide, at mayzent.com.




















      Novartis Logo

      Novartis Pharmaceuticals Corporation

      East Hanover, New Jersey 07936-1080

      MAYZENT and the MAYZENT logo are registered trademarks of Novartis AG.

      © 2023 Novartis

      9/23

      290141